Decompressive hemicraniectomy after malignant middle cerebral artery infarction: Rationale and controversies

Omar M. Arnaout, Salah G. Aoun, H. Hunt Batjer, Bernard R. Bendok

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Malignant middle cerebral artery stroke carries a very poor prognosis. Significant retrospective data support the hypothesis that decompressive hemicraniectomy decreases mortality rates due to this disease entity. Recently, 3 randomized controlled studies have been published and shed light on these issues and enhance the quality of evidence revolving around this procedure. In this review, the rationale, risks, benefits, and unanswered questions related to hemicraniectomy for acute ischemic stroke are reviewed with an emphasis on how 3 randomized trials have influenced knowledge on this life-saving yet controversial procedure. Further randomized studies are needed to clarify lingering questions regarding age indications and impact on quality of life.

Original languageEnglish (US)
Article numberE18
JournalNeurosurgical Focus
Volume30
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Middle Cerebral Artery Infarction
Stroke
Quality of Life
Mortality

Keywords

  • Craniectomy
  • Hemicraniectomy
  • Malignant stroke
  • Patient outcome
  • Quality of life
  • Randomized controlled trial

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Decompressive hemicraniectomy after malignant middle cerebral artery infarction : Rationale and controversies. / Arnaout, Omar M.; Aoun, Salah G.; Batjer, H. Hunt; Bendok, Bernard R.

In: Neurosurgical Focus, Vol. 30, No. 6, E18, 06.2011.

Research output: Contribution to journalArticle

@article{bd90ad0fa8724e61a5da4cedc73eb3b9,
title = "Decompressive hemicraniectomy after malignant middle cerebral artery infarction: Rationale and controversies",
abstract = "Malignant middle cerebral artery stroke carries a very poor prognosis. Significant retrospective data support the hypothesis that decompressive hemicraniectomy decreases mortality rates due to this disease entity. Recently, 3 randomized controlled studies have been published and shed light on these issues and enhance the quality of evidence revolving around this procedure. In this review, the rationale, risks, benefits, and unanswered questions related to hemicraniectomy for acute ischemic stroke are reviewed with an emphasis on how 3 randomized trials have influenced knowledge on this life-saving yet controversial procedure. Further randomized studies are needed to clarify lingering questions regarding age indications and impact on quality of life.",
keywords = "Craniectomy, Hemicraniectomy, Malignant stroke, Patient outcome, Quality of life, Randomized controlled trial",
author = "Arnaout, {Omar M.} and Aoun, {Salah G.} and Batjer, {H. Hunt} and Bendok, {Bernard R.}",
year = "2011",
month = "6",
doi = "10.3171/2011.3.FOCUS1160",
language = "English (US)",
volume = "30",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "6",

}

TY - JOUR

T1 - Decompressive hemicraniectomy after malignant middle cerebral artery infarction

T2 - Rationale and controversies

AU - Arnaout, Omar M.

AU - Aoun, Salah G.

AU - Batjer, H. Hunt

AU - Bendok, Bernard R.

PY - 2011/6

Y1 - 2011/6

N2 - Malignant middle cerebral artery stroke carries a very poor prognosis. Significant retrospective data support the hypothesis that decompressive hemicraniectomy decreases mortality rates due to this disease entity. Recently, 3 randomized controlled studies have been published and shed light on these issues and enhance the quality of evidence revolving around this procedure. In this review, the rationale, risks, benefits, and unanswered questions related to hemicraniectomy for acute ischemic stroke are reviewed with an emphasis on how 3 randomized trials have influenced knowledge on this life-saving yet controversial procedure. Further randomized studies are needed to clarify lingering questions regarding age indications and impact on quality of life.

AB - Malignant middle cerebral artery stroke carries a very poor prognosis. Significant retrospective data support the hypothesis that decompressive hemicraniectomy decreases mortality rates due to this disease entity. Recently, 3 randomized controlled studies have been published and shed light on these issues and enhance the quality of evidence revolving around this procedure. In this review, the rationale, risks, benefits, and unanswered questions related to hemicraniectomy for acute ischemic stroke are reviewed with an emphasis on how 3 randomized trials have influenced knowledge on this life-saving yet controversial procedure. Further randomized studies are needed to clarify lingering questions regarding age indications and impact on quality of life.

KW - Craniectomy

KW - Hemicraniectomy

KW - Malignant stroke

KW - Patient outcome

KW - Quality of life

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=79958818398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958818398&partnerID=8YFLogxK

U2 - 10.3171/2011.3.FOCUS1160

DO - 10.3171/2011.3.FOCUS1160

M3 - Article

C2 - 21631219

AN - SCOPUS:79958818398

VL - 30

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 6

M1 - E18

ER -